Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD Study of Intravenous Ferric Carboxymaltose in Pediatric Iron Deficiency Anemia
2014-004232-19Phase 2Completed
- Sponsor
- Luitpold Pharmaceuticals
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by Luitpold Pharmaceuticals. Primary endpoints: Pharmacokinetic profile of ferric carboxymaltose, Pharmacodynamic effects and 1 more. Started Dec 2014; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2014-004232-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004232-19.